Synthesis of Trelagliptin Succinate
暂无分享,去创建一个
S. Xu | Hongyan Li | Qun Hao | Zhenren Liu | Wei-cheng Zhou
[1] P. Ouyang,et al. Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds. , 2016, Journal of pharmaceutical and biomedical analysis.
[2] H. Ueno,et al. Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism , 2016, PloS one.
[3] N. Inagaki,et al. Long‐term safety and efficacy of a novel once‐weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52‐week open‐label, phase 3 study , 2016, Journal of diabetes investigation.
[4] N. Inagaki,et al. Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study. , 2015, The lancet. Diabetes & endocrinology.
[5] H. Couthon-Gourvès,et al. Atherton–Todd reaction: mechanism, scope and applications , 2014, Beilstein journal of organic chemistry.
[6] D. Kassel,et al. Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV. , 2011, Journal of medicinal chemistry.
[7] Y. Tu,et al. An Efficient Method for the Preparation of Benzylic Bromides , 2001 .